Injective vs Solana — how do they compare? Injective trades at Rp92,485 (market cap Rp9,27T, Rp1,76T 24h volume), while Solana trades at Rp1,393,952 (market cap Rp812,91T, Rp38,81T 24h volume). The key difference: Solana is far larger — about 87.7× Injective's market cap, and Injective's circulating supply is 100M INJ versus 582,4M SOL for Solana. Which is the better fit depends on your goals — on Pluang, investors hold Injective for 36 Days and Solana for 66 Days on average.
| INJ | SOL | |
|---|---|---|
Market Cap | Rp9,27T | Rp812,91T |
Volume (24h) | Rp1,76T | Rp38,81T |
Circulating Supply | 100M INJ | 582,4M SOL |
Typical Hold Time | 36 Days | 66 Days |
Signals from Pluang's Aura AI — not financial advice
Injective (INJ) is trading at Rp92,221 with a market cap of Rp9.18T, showing a bullish technical signal overall. The moving averages are strongly bullish, while oscillators are neutral. Key resistance lies at Rp93,589 and support at Rp86,188. The asset has a hold time of 36 days, indicating moderate holding behavior. No major protocol updates or ecosystem news are noted recently, but the token remains active in decentralized exchange and DeFi sectors.
Overall outlook is cautiously optimistic due to bullish technicals, but risks include high volatility and neutral oscillators suggesting potential consolidation. Opportunities lie in continued ecosystem growth, while major risks involve crypto market sentiment shifts and regulatory uncertainties. Investors should monitor key resistance levels for breakout signals.
Solana trades at Rp1,394,268 with neutral technical signals overall, though moving averages show bullish momentum. The token faces resistance at Rp1,428,705 and support at Rp1,367,283. Recent ecosystem growth includes SOL Strategies surpassing 31,000 unique wallets and launching a liquid staking platform with over 500,000 SOL staked, indicating strong institutional and retail adoption.
Outlook is cautiously optimistic with potential for upside if altcoin season materializes, but risks include high volatility and regulatory uncertainty. Key opportunities lie in Solana's speed advantage and growing DeFi integration, while major risks involve market-wide crypto corrections and technical vulnerabilities.
What Pluang investors did over the last 30 days
Latest headlines on both assets
Injective enables access to unlimited DeFi markets. Users can create any financial market on Injective's fast, cross-chain, zero gas fee, secure, and fully decentralized exchange protocol. The trading infrastructure of Injective is supported entirely by a central limit order book that integrates the user-friendly interface and speed of centralized exchanges with the transparency of decentralized exchanges. Native token INJ is a scarce asset that used for governance, exchange value capture, liquidity mining, and staking.
Read more on INJ →SOL is the native token of Solana, an open source project which implements a new, high-performance, permission less blockchain. It is also the fastest blockchain in the world and the fastest growing ecosystem in crypto, with over 400 projects spanning DeFi, NFTs, Web3 and more. The architecture of their blockchain are build based on Proof of History (PoH); a proof for verifying order and passage of time between events.
Read more on SOL →